We've updated our Privacy Policy to make it clearer how we use your personal data.

We use cookies to provide you with a better experience. You can read our Cookie Policy here.

Advertisement

SYGNIS Presents its First Own Product Line: TruePrime™


Want a FREE PDF version of This Product News?

Complete the form below and we will email you a PDF version of "SYGNIS Presents its First Own Product Line: TruePrime™"

Technology Networks Ltd. needs the contact information you provide to us to contact you about our products and services. You may unsubscribe from these communications at any time. For information on how to unsubscribe, as well as our privacy practices and commitment to protecting your privacy, check out our Privacy Policy

SYGNIS AG has announced the inaugural launch of its first new product line TruePrime™.

TruePrime™ is the brand name of a series of kits dedicated to the amplification of various DNA or RNA species for a multitude of applications. TruePrime™ stands for a revolutionary change in the way DNA or RNA is amplified. While the current gold standard MDA (multiple displacement amplification) needs short pieces of DNA (“oligonucleotides”) to start off the amplification, TruePrime™ does not need any synthetic random primers.

TruePrime™ is based on a combination of SYGNIS’ recently discovered polymerase TthPrimPol and Phi29 DNA polymerase. In this set up, TthPrimPol synthesizes the primers needed for Phi29 DNA pol on the fly, which allows for the amplification of genomic DNAs.

The key advantages of the TruePrime™ product line include complete absence of common artifacts linked to the use of oligonucleotides, a reduced amplification bias compared to methods using random synthetic primers and an exquisite reproducibility when DNA is amplified from single mammalian cells.

Moreover, TruePrime™ shows superior sensitivity, is easy to use and works perfectly well with all commonly used NGS platforms such as Illumina and IonTorrent. The Company plans to launch the first kit for DNA amplification from single cells in January of 2015.

Single cell analysis has been named “Method of the year” by the renowned journal “Nature Methods” and is one of the most exciting but also one of the most challenging applications of NGS. The features of TruePrime™ make this product highly attractive for this type of analyses especially in life science areas such as human genetics, oncology, or pathology where researchers need to obtain biological information from the smallest sample amounts.

“We are very proud and excited about the development of our first kit from our newly introduced TruePrime™ product line. With this product line, based on our proprietary PrimPol technology, we are addressing key challenges in NGS as well as in other downstream applications, where DNA analysis is limited due to small amounts of available sample material down to single cells,” Pilar de la Huerta, CEO and CFO of SYGNIS commented.

Huerta continued, “In addition, we are driving adoption of NGS into more commercial applications by providing solutions which are compatible with major NGS platforms and support standardization of workflows. Given the superiority of TruePrime™ over all technologies for whole genome DNA amplification available today, SYGNIS is convinced it will benefit from future growth rates and gain a significant portion of the market.”

SYGNIS is currently developing a series of TruePrime™ kits that are expected to be launched throughout 2015 and 2016 to bring the benefits of this new technology to researchers working on a variety of applications. Starting January 2015, the kits will be available via SYGNIS’ own sales channels and through regional and international life science distributors. In addition, SYGNIS is planning to also expand the market for its new products through OEM agreements with international market leading companies.

SYGNIS has cloned, characterized, and patented a PrimPol thermostable version, TthPrimPol, following the seminal characterization of human PrimPol by one of SYGNIS’ scientific fathers, Prof. Luis Blanco, at the end of 2013.

On November 12th, Prof. Blanco was granted with the renowned Carmen and Severo Ochoa Prize 2014 by the Carmen and Severo Ochoa Foundation from the Spanish National Research Council (CSIC), which recognizes the work of excellent scientists in the field of molecular biology in Spain. This brand new amplification technology is patent-protected by SYGNIS until 2033.

Advertisement